Larimar Therapeutics, Inc. (LRMR)
NASDAQ·Healthcare·Biotechnology
$2.48
+3.56%
Mkt Cap $248.28M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$8.00
Range $5.00 – $11.00
Implied Upside
+223.2%
Consensus $8.00 vs current $2.48
NASDAQ·Healthcare·Biotechnology
$2.48
+3.56%
Mkt Cap $248.28M
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$8.00
Range $5.00 – $11.00
+223.2%
Consensus $8.00 vs current $2.48